The brain slows and dulls with age. Could a drug flip a single switch and turn that around? A 2026 review puts its bet on SIRT1, the NAD⁺-dependent enzyme whose depletion in the brain is tied to cognitive decline and dementia. Promising, but still far from a human prescription.